Cardiovascular Devices Market to 2017 - Minimally Invasive Techniques and Cardiac Prosthetic Devices to Drive Future Growth

Document Sample
Cardiovascular Devices Market to 2017 - Minimally Invasive Techniques and Cardiac Prosthetic Devices to Drive Future Growth Powered By Docstoc
					   Cardiovascular Devices Market to 2017 - Minimally Invasive
   Techniques and Cardiac Prosthetic Devices to Drive Future
                           Growth
 Reference Code: GBIME0048MR                                                                                                  Publication Date: February 2012


                                   The Global Cardiovascular Devices Market is Forecast to Reach $43.4 Billion by 2017
   The global cardiovascular
   devices market is forecast       Cardiovascular Devices Market, Global, Overall Revenues ($bn), 2010–2017
   to grow at a Compound
   Annual Growth Rate                                     50
   (CAGR) of 4% during the
                                                          45
   period 2010-2017 to reach
   $43.4 billion by 2017                                  40

                                                          35
                                          Revenue ($bn)




                                                          30

                                                          25

                                                          20

                                                          15

                                                          10

                                                           5

                                                           0
                                                                              2010                         2014                             2017
                                                          Cardiac Rhythm Management                          Interventional Cardiology
                                                          Peripheral Vascular Devices                        Cardiovascular Surgery
                                                          Prosthetic Heart Valves                            External Defibrillators
                                                          Electrophysiology                                  Cardiovascular Monitoring and Diagnostic Devices
                                                          Cardiac Assist Devices                             Cardiovascular Prosthetic Devices



                                    Source: GBI Research, Company Annual Reports and Interviews with Industry Experts and Key Opinion Leaders




                                   The global cardiovascular devices market is forecast to grow at a Compound Annual Growth Rate
                                   (CAGR) of 4% during the period 2010-2017 to reach $43.4 billion by 2017.
                                   The cardiovascular devices market will be driven by an increase in the incidence of Cardiovascular
                                   Diseases (CVDs), an increasing elderly population across the globe, an increase in risk factors
                                   such as diabetes, smoking, and hypertension leading to CVDs and the greater adoption of
                                   technological advancements. According to the World Health Organization (WHO), CVDs are the
                                   leading causes of death and disability in the world. In 2008, CVDs were responsible for 17.3 million
                                   deaths. Heart attacks were responsible for 7.3 million and strokes were responsible for 6.2 million
                                   deaths.
                                   According to the WHO, there will be about 23.6 million deaths from CVD by 2030, primarily from
                                   heart disease and stroke. The incidence of CVD is expected to increase further in future due to an
                                   increase in behavioral risk factors, such as smoking, poor nutrition, lack of physical movement,
                                   type-A personality, high alcohol consumption and drug abuse. Behavioral risk factors are
                                   responsible for about 80% of coronary heart disease and cerebrovascular disease.




Cardiovascular Devices Market to 2017 - Minimally Invasive                                                                  GBIME0048MR / Published FEB 2012
Techniques and Cardiac Prosthetic Devices to Drive Future                                                                                                  Page 1
Growth                                                                                  © GBI Research. This report is a licensed product and is not to be copied,
                                                                                                                        reproduced, shared or resold in any form
                                   Cardiac Rhythm Management Devices is the Largest Category in the Global Cardiovascular
                                   Devices Market

                                    Cardiovascular Devices Market, Global, Category Share by Revenue Contribution (%),
                                    2010

                                                                                                      Cardiac Assist Devices
                                                                              Electrophysiology                2%
                                                                                     4%
                                                                                                          Cardiovascular Prosthetic
                                                               Cardiovascular Monitoring                          Devices
                                                                and Diagnostic Devices                              1%
                                                                         3%
                                                                External Defibrillators
                                                                         4%                                                   Cardiac Rhythm
                                                          Prosthetic Heart Valves                                              Management
                                                                    4%                                                             35%

                                                         Cardiovascular Surgery
                                                                  5%




                                                              Peripheral Vascular
                                                                   Devices
                                                                     13%




                                                                                                  Interventional Cardiology
                                                                                                             29%


                                    Source: GBI Research, Company Annual Reports and Interviews with Industry Experts and Key Opinion Leaders




                                   The Cardiac Rhythm Management (CRM) devices category was the largest category in the global
                                   cardiovascular devices market in 2010. The CRM market accounted for about 35% of the overall
                                   cardiovascular devices market.
                                   The global CRM market was valued at $11.39 billion in 2010 and is forecast to grow at a CAGR of
                                   4% to reach $15.16 billion in 2017. Within this category ‘pacemakers’ was the largest segment. The
                                   market for CRM has grown over the past five decades due to improved device function, advances
                                   in technology and implantation techniques, and a rapidly expanding set of clinical indications.




Cardiovascular Devices Market to 2017 - Minimally Invasive                                                        GBIME0048MR / Published FEB 2012
Techniques and Cardiac Prosthetic Devices to Drive Future                                                                                        Page 2
Growth                                                                        © GBI Research. This report is a licensed product and is not to be copied,
                                                                                                              reproduced, shared or resold in any form
                                   Technological Advances and Minimally Invasive Procedures to Drive the Cardiovascular
                                   Devices Market
                                   The innovations in technology and design of cardiovascular devices in past the few years have led
                                   to an increase in the demand for cardiovascular devices. The modern day devices such as
                                   Magnetic Resonance Imaging (MRI) compatible pacemakers will increase the demand for
                                   pacemakers as the majority of patients require an MRI after implantation. Other innovative products
                                   such as artificial hearts, bioresorbable stents, tissue heart valves and heart rhythm devices with
                                   wireless telemetry features are driving the cardiovascular devices market. Along with these
                                   innovations, cardiovascular procedures which are minimally invasive are also resulting in the
                                   growth of cardiovascular procedure volumes. Procedures such as balloon angioplasty and
                                   Percutaneous Coronary Intervention (PCI) are minimally invasive techniques. Transcatheter heart
                                   valve replacement is a minimally invasive technique for heart valve replacement. Heart Valve
                                   surgeries, including valve repairs and valve replacements, are the most common minimally invasive
                                   heart surgery procedures.
                                   Procedures such as Minimally Invasive Direct Coronary Artery Bypass Graft (MIDCAB), Port-
                                   Access Coronary Artery Bypass (also referred to as PACAB or PortCAB), Off-Pump Coronary
                                   Artery Bypass (OPCAB), Robotic Assisted Coronary Artery Bypass (RACAB) and Totally
                                   Endoscopic Coronary Artery Bypass Graft (TECAB) are minimally invasive procedures. Procedures
                                   such as balloon angioplasty and Percutaneous Coronary Intervention (PCI) are minimally invasive
                                   techniques. Endovascular Aortic Repair (EVAR) is a procedure to treat abdominal aneurysms
                                   endovascularly and is minimally invasive. Transcatheter heart valve replacement is a minimally
                                   invasive technique for heart valve replacement. Heart valve surgeries, including valve repairs and
                                   valve replacements, are the most common minimally invasive heart surgery procedures. Other
                                   procedures such as epicardial lead placement: placement of leads for biventricular pacemakers
                                   (cardiac resynchronization therapy), transmyocardial laser revascularization and minimally invasive
                                   radiofrequency ablation for atrial fibrillation are also minimally invasive procedures.
                                   The advantages of minimally invasive surgeries include less pain, lower risk of infection, reduced
                                   blood loss, reduced Intensive Care Unit (ICU) and hospital stays, improved postoperative
                                   pulmonary function, fast recovery and improved quality of life have increased the patient
                                   satisfaction. These advantages are driving younger patients to undergo surgery as they need less
                                   recuperation time and can get back to work sooner. The minimally invasive techniques are also
                                   advantageous to the elderly and high risk patients as there are fewer traumas associated with the
                                   procedure and a lower risk of infection.




Cardiovascular Devices Market to 2017 - Minimally Invasive                                              GBIME0048MR / Published FEB 2012
Techniques and Cardiac Prosthetic Devices to Drive Future                                                                              Page 3
Growth                                                              © GBI Research. This report is a licensed product and is not to be copied,
                                                                                                    reproduced, shared or resold in any form
                                   Medtronic, Inc. to Dominate Global Cardiovascular Devices Market

    Medtronic holds the             Cardiovascular Devices Market, Global, Key Company Shares (%), 2010
    leading market position
    with 23% of the                                                                                    Medtronic, Inc.
    cardiovascular devices                                                                                 23%
    market share


                                                           Others
                                                            42%




                                                                                                              Boston Scientific
                                                                                                                Corporation
                                                                                                                   15%



                                                                                                  St. Jude Medical,
                                                                    Abbott Laboratories
                                                                                                         Inc.
                                                                            9%
                                                                                                         11%

                                    Source: GBI Research, Company Annual Reports and Interviews with Industry Experts and Key Opinion Leaders




                                   Medtronic holds the leading market position with 23% of the cardiovascular devices market share It
                                   has a wide product portfolio with products in pacing systems and implantable cardiac rhythm
                                   devices. The acquisition of Invatec and two affiliated companies, Fogazzi and Krauth
                                   Cardiovascular, as well as the $370m purchase of ATS Medical Inc. in 2010, played an important
                                   role in maintaining Medtronic’s market share in the cardiovascular devices market. The Invatech
                                   deal broadened the product portfolio of Medtronic and enabled it to market drug-eluting balloons
                                   covering the coronaries and lower extremities, while the ATS merger enabled the company to
                                   provide open-pivot bileaflet mechanical and 3f pericardial valve technology to cardiac surgeons.
                                   Other major companies in the industry are Boston scientific with a 15% market share, St. Jude
                                   Medical with 11% and Abbott laboratories with 9%. The cardiovascular devices market is
                                   dominated by these four major companies, which together capture a 59% market share. The
                                   market is fragmented with many smaller companies operating in the market. These smaller
                                   companies include Cordis, Terumo and Sorin. Companies such as Edwards LifeSciences, C.R.
                                   Bard, Biosense Webster, Philips Healthcare and Biotronik also have very good product portfolios
                                   for specific categories in the cardiovascular devices market.




Cardiovascular Devices Market to 2017 - Minimally Invasive                                                    GBIME0048MR / Published FEB 2012
Techniques and Cardiac Prosthetic Devices to Drive Future                                                                                    Page 4
Growth                                                                    © GBI Research. This report is a licensed product and is not to be copied,
                                                                                                          reproduced, shared or resold in any form
                                   1         Table of Contents
                                   1 Table of Contents ........................................................................................................................ 5
                                     1.1    List of Tables................................................................................................................... 10
                                     1.2    List of Figures ................................................................................................................. 13
                                   2 Introduction ................................................................................................................................ 15
                                     2.1    GBI Research Guidance ................................................................................................. 15
                                   3 Global Cardiovascular Devices - Market Characterization ........................................................ 16
                                     3.1    Global Cardiovascular Devices Market, Revenue ($bn), 2003-2010 .............................. 16
                                     3.2    Global Cardiovascular Devices Market, Revenue ($bn), 2010-2017 .............................. 17
                                     3.3    Global Cardiovascular Devices Market, Key Company Shares (%), 2010 ...................... 18
                                     3.4    Global Cardiovascular Devices Market, Key Trends ....................................................... 19
                                        3.4.1    Industry Consolidation Taking Place in Cardiovascular Devices Market through
                                                 Mergers and Acquisitions is Changing the Competitive Landscape ........................ 19
                                        3.4.2    Cardiovascular Diseases Continue to be the Number One Cause of Death
                                                 Worldwide ................................................................................................................ 20
                                        3.4.3    The Increased use of Percutaneous Coronary Intervention (PCI) Compared to
                                                 Coronary Artery Bypass Grafts (CABG) Continues to Drive the Cardiovascular
                                                 Devices Market Growth ........................................................................................... 20
                                     3.5    Global Cardiovascular Devices, Market Dynamics ......................................................... 21
                                        3.5.1    Market Drivers ......................................................................................................... 21
                                        3.5.2    Market Restraints .................................................................................................... 24
                                   4 Global Cardiovascular Devices Market - Category Analysis and Forecasts .............................. 25
                                     4.1    Cardiac Rhythm Management Devices ........................................................................... 25
                                        4.1.1    Cardiac Rhythm Management Devices Market, Global, Revenue ($m), 2003-2010 25
                                        4.1.2    Cardiac Rhythm Management Market, Global, Revenue ($m), 2010-2017 ............. 26
                                        4.1.3    Cardiac Rhythm Management Market, Global, Key Company Shares (%), 2010.... 27
                                     4.2    Cardiac Rhythm Management - Market Dynamics.......................................................... 28
                                        4.2.1    Market Drivers ......................................................................................................... 28
                                        4.2.2    Market Restraints .................................................................................................... 29
                                     4.3    Interventional Cardiology ................................................................................................ 30
                                        4.3.1    Interventional Cardiology, Global, Revenue ($m), 2003-2010 ................................. 30
                                        4.3.2    Interventional Cardiology Market, Global, Revenue ($m), 2010-2017 ..................... 32
                                        4.3.3    Interventional Cardiology Market, Global, Key Company Shares (%), 2010 ........... 33
                                     4.4    Interventional Cardiology - Market Dynamics.................................................................. 34
                                        4.4.1    Market Drivers ......................................................................................................... 34
                                        4.4.2    Market Restraints .................................................................................................... 36
                                     4.5    Peripheral Vascular Devices ........................................................................................... 37
                                        4.5.1    Peripheral Vascular Devices Market, Global, Revenue ($m), 2003-2010................ 37
                                        4.5.2    Peripheral Vascular Devices Market, Global, Revenue ($m), 2010-2017................ 39
                                        4.5.3    Peripheral Vascular Devices Market, Global, Key Company Shares (%), 2010 ...... 41
                                     4.6    Peripheral Vascular Devices - Market Dynamics ............................................................ 42
                                        4.6.1    Market Drivers ......................................................................................................... 42
                                        4.6.2    Market Restraints .................................................................................................... 43
                                     4.7    Cardiovascular Surgery Devices ..................................................................................... 44
                                        4.7.1    Cardiovascular Surgery Devices Market, Global, Revenue ($m), 2003-2010 ......... 44
                                        4.7.2    Cardiovascular Surgery Devices Market, Global, Revenue Forecasts ($m), 2010-
                                                 2017 ........................................................................................................................ 45
                                        4.7.3    Cardiovascular Surgery Devices Market, Global, Key Company Shares (%), 2010 46
                                     4.8    Cardiovascular Surgery Devices - Market Dynamics ...................................................... 47
                                        4.8.1    Market Drivers ......................................................................................................... 47
                                        4.8.2    Market Restraints .................................................................................................... 47
                                     4.9    Prosthetic Heart Valves .................................................................................................. 48
                                        4.9.1    Prosthetic Heart Valves Market, Global, Revenue ($m), 2003-2010 ....................... 48
                                        4.9.2    Prosthetic Heart Valves Market, Global, Revenue ($m), 2010-2017 ....................... 49
                                        4.9.3    Prosthetic Heart Valves Market, Global, Key Company Shares (%), 2010.............. 50

Cardiovascular Devices Market to 2017 - Minimally Invasive                                                              GBIME0048MR / Published FEB 2012
Techniques and Cardiac Prosthetic Devices to Drive Future                                                                                              Page 5
Growth                                                                              © GBI Research. This report is a licensed product and is not to be copied,
                                                                                                                    reproduced, shared or resold in any form
                                     4.10 Prosthetic Heart Valves - Market Dynamics .................................................................... 51
                                        4.10.1 Market Drivers ......................................................................................................... 51
                                        4.10.2 Market Restraints .................................................................................................... 52
                                     4.11 External Defibrillators ...................................................................................................... 53
                                        4.11.1 External Defibrillators, Global, Revenue ($m), 2003-2010 ...................................... 53
                                        4.11.2 External Defibrillators, Global, Revenue ($m), 2010-2017 ...................................... 54
                                        4.11.3 External Defibrillators, Global, Key Company Shares (%), 2010 ............................. 55
                                     4.12 External Defibrillators - Market Dynamics ....................................................................... 56
                                        4.12.1 Market Drivers ......................................................................................................... 56
                                        4.12.2 Market Restraints .................................................................................................... 57
                                     4.13 Electrophysiology ............................................................................................................ 58
                                        4.13.1 Electrophysiology, Global, Revenue ($m), 2003-2010 ............................................ 58
                                        4.13.2 Electrophysiology, Global, Revenue ($m), 2010-2017 ............................................ 59
                                        4.13.3 Electrophysiology, Global, Key Company Shares (%), 2010 ................................... 60
                                     4.14 Electrophysiology - Market Dynamics ............................................................................. 61
                                        4.14.1 Market Drivers ......................................................................................................... 61
                                        4.14.2 Market Restraints .................................................................................................... 62
                                     4.15 Cardiovascular Monitoring and Diagnostic Devices ........................................................ 64
                                        4.15.1 Cardiovascular Monitoring and Diagnostic Devices Market, Global, Revenue ($m),
                                                 2003-2010 ............................................................................................................... 64
                                        4.15.2 Cardiovascular Monitoring and Diagnostic Devices Market, Global, Revenue
                                                 Forecast ($m), 2010-2017 ....................................................................................... 65
                                        4.15.3 Cardiovascular Monitoring and Diagnostic Devices Market, Global, Key Company
                                                 Shares (%), 2010..................................................................................................... 66
                                     4.16 Cardiovascular Monitoring and Diagnostic Devices - Market Dynamics ......................... 67
                                        4.16.1 Market Drivers ......................................................................................................... 67
                                        4.16.2 Market Restraints .................................................................................................... 68
                                     4.17 Cardiac Assist Devices ................................................................................................... 69
                                        4.17.1 Cardiac Assist Devices Market, Global, Revenue ($m), 2003-2010 ........................ 69
                                        4.17.2 Cardiac Assist Devices Market, Global, Revenue ($m), 2010-2017 ........................ 70
                                        4.17.3 Cardiac Assist Devices Market, Global, Key Company Shares (%), 2010 .............. 71
                                     4.18 Cardiac Assist Devices - Market Dynamics..................................................................... 72
                                        4.18.1 Market Drivers ......................................................................................................... 72
                                        4.18.2 Market Restraints .................................................................................................... 73
                                     4.19 Cardiovascular Prosthetic Devices ................................................................................. 74
                                        4.19.1 Cardiovascular Prosthetic Devices Market, Global, Revenue ($m), 2003-2010 ...... 74
                                        4.19.2 Cardiovascular Prosthetic Devices Market, Global, Revenue ($m), 2010-2017 ...... 75
                                        4.19.3 Cardiovascular Prosthetic Devices Market, Global, Key Company Shares (%), 2010
                                                 76
                                     4.20 Cardiovascular Prosthetic Devices - Market Dynamics ................................................... 77
                                        4.20.1 Market Drivers ......................................................................................................... 77
                                        4.20.2 Market Restraints .................................................................................................... 77
                                   5 Global Cardiovascular Devices Market - Country Analysis and Forecasts ................................ 78
                                     5.1    Cardiovascular Devices Market - Cross-Country Analysis .............................................. 78
                                     5.2    Historic (2003-2010) and Forecast (2010-2017) Revenue, By Country .......................... 80
                                        5.2.1    Cardiovascular Devices Market, The US, Revenue ($m), 2003-2010 ..................... 80
                                        5.2.2    Cardiovascular Devices Market, The US, Revenue ($m), 2010-2017 ..................... 82
                                        5.2.3    Cardiovascular Devices Market, Canada, Revenue ($m), 2003-2010 ..................... 84
                                        5.2.4    Cardiovascular Devices Market, Canada, Revenue ($m), 2010-2017 ..................... 85
                                        5.2.5    Cardiovascular Devices Market, The UK, Revenue ($m), 2003-2010 ..................... 86
                                        5.2.6    Cardiovascular Devices Market, The UK, Revenue ($m), 2010-2017 ..................... 87
                                        5.2.7    Cardiovascular Devices Market, Germany, Revenue ($m), 2003-2010................... 89
                                        5.2.8    Cardiovascular Devices Market, Germany, Revenue, ($m), 2010-2017.................. 91
                                        5.2.9    Cardiovascular Devices Market, France, Revenue ($m), 2003-2010 ...................... 93
                                        5.2.10 Cardiovascular Devices Market, France, Revenue Forecast ($m), 2010-2017 ....... 95


Cardiovascular Devices Market to 2017 - Minimally Invasive                                                           GBIME0048MR / Published FEB 2012
Techniques and Cardiac Prosthetic Devices to Drive Future                                                                                           Page 6
Growth                                                                           © GBI Research. This report is a licensed product and is not to be copied,
                                                                                                                 reproduced, shared or resold in any form
                                        5.2.11 Cardiovascular Devices Market, Italy, Revenue ($m), 2003-2010 ........................... 97
                                        5.2.12 Cardiovascular Devices Market, Italy, Revenue Forecast ($m), 2010-2017 ............ 99
                                        5.2.13 Cardiovascular Devices Market, Spain, Revenue ($m), 2003-2010 ...................... 101
                                        5.2.14 Cardiovascular Devices Market, Spain, Revenue ($m), 2010-2017 ...................... 102
                                        5.2.15 Cardiovascular Devices Market, Japan, Revenue ($m), 2003-2010...................... 104
                                        5.2.16 Cardiovascular Devices Market, Japan, Revenue Forecast ($m), 2010-2017....... 106
                                        5.2.17 Cardiovascular Devices Market, China, Revenue ($m), 2003-2010 ...................... 108
                                        5.2.18 Cardiovascular Devices Market, China, Revenue Forecast ($m), 2010-2017 ....... 110
                                        5.2.19 Cardiovascular Devices Market, India, Revenue ($m), 2003-2010........................ 112
                                        5.2.20 Cardiovascular Devices Market, India, Revenue Forecast ($m), 2010-2017......... 113
                                        5.2.21 Cardiovascular Devices Market, Australia, Revenue ($m), 2003-2010 ................. 114
                                        5.2.22 Cardiovascular Devices Market, Australia, Revenue ($m), 2010-2017 ................. 116
                                        5.2.23 Cardiovascular Devices Market, Brazil, Revenue ($m), 2003-2010 ...................... 117
                                        5.2.24 Cardiovascular Devices Market, Brazil, Revenue ($m), 2010-2017 ...................... 118
                                   6 Global Cardiovascular Devices Market - Competitive Assessment ......................................... 119
                                     6.1    Boston Scientific Corporation ........................................................................................ 120
                                        6.1.1     Overview ............................................................................................................... 120
                                        6.1.2     Key Marketed Products ......................................................................................... 121
                                     6.2    Medtronic, Inc ............................................................................................................... 121
                                        6.2.1     Business Overview ................................................................................................ 121
                                        6.2.2     Key Marketed Products ......................................................................................... 122
                                     6.3    St. Jude Medical, Inc..................................................................................................... 122
                                        6.3.1     Business Overview ................................................................................................ 122
                                        6.3.2     Key Marketed Products ......................................................................................... 122
                                     6.4    Abbott Laboratories....................................................................................................... 123
                                        6.4.1     Business Overview ................................................................................................ 123
                                        6.4.2     Key Marketed Products ......................................................................................... 123
                                     6.5    Cordis ........................................................................................................................... 124
                                        6.5.1     Business Overview ................................................................................................ 124
                                        6.5.2     Key Marketed Products ......................................................................................... 124
                                     6.6    Terumo Corporation ...................................................................................................... 124
                                        6.6.1     Business Overview ................................................................................................ 124
                                        6.6.2     Key Marketed Products ......................................................................................... 124
                                     6.7    Sorin Group................................................................................................................... 125
                                        6.7.1     Business Overview ................................................................................................ 125
                                        6.7.2     Key Marketed Products ......................................................................................... 125
                                     6.8    Phillips Healthcare ........................................................................................................ 125
                                        6.8.1     Business Overview ................................................................................................ 125
                                        6.8.2     Key Marketed Products ......................................................................................... 125
                                     6.9    Edwards Lifesciences Corporation................................................................................ 126
                                        6.9.1     Business Overview ................................................................................................ 126
                                        6.9.2     Key Marketed Products ......................................................................................... 126
                                     6.10 C.R. Bard, Inc. .............................................................................................................. 126
                                        6.10.1 Business Overview ................................................................................................ 126
                                        6.10.2 Key Marketed Products ......................................................................................... 126
                                     6.11 Biosense Webster, Inc. ................................................................................................. 126
                                        6.11.1 Business Overview ................................................................................................ 126
                                        6.11.2 Key Marketed Products ......................................................................................... 126
                                     6.12 BIOTRONIK SE & Co. KG ............................................................................................ 127
                                        6.12.1 Business Overview ................................................................................................ 127
                                        6.12.2 Key Marketed Products ......................................................................................... 127
                                   7 Global Cardiovascular Devices Market - Product Pipeline Analysis ........................................ 128
                                     7.1    Interventional Cardiology .............................................................................................. 128
                                     7.2    Interventional Cardiology - List of Pipeline Products ..................................................... 129
                                     7.3    Profiles of Key Pipeline Products - Interventional cardiology ........................................ 137

Cardiovascular Devices Market to 2017 - Minimally Invasive                                                             GBIME0048MR / Published FEB 2012
Techniques and Cardiac Prosthetic Devices to Drive Future                                                                                             Page 7
Growth                                                                             © GBI Research. This report is a licensed product and is not to be copied,
                                                                                                                   reproduced, shared or resold in any form
                                         7.3.1    Coronary Stents..................................................................................................... 137
                                         7.3.2    PTCA Balloons ...................................................................................................... 138
                                         7.3.3    Cardiac Catheters.................................................................................................. 139
                                         7.3.4    Coronary Guidewires ............................................................................................. 140
                                         7.3.5    Arteriotomy Closure Devices ................................................................................. 140
                                         7.3.6    Intravascular Ultra Sound System ......................................................................... 141
                                         7.3.7    PTCA Coronary Drug Eluting Balloons (DEB) ....................................................... 141
                                      7.4    Peripheral Vascular Devices ......................................................................................... 142
                                      7.5    Peripheral Vascular Devices - List of Pipeline Products ............................................... 143
                                      7.6    Profiles of Key Pipeline Products - Peripheral Vascular Devices ................................. 150
                                         7.6.1    Peripheral Vascular Stents .................................................................................... 150
                                         7.6.2    Stent Grafts ........................................................................................................... 151
                                         7.6.3    PTA Balloons ......................................................................................................... 152
                                         7.6.4    Synthetic Surgical Grafts ....................................................................................... 152
                                         7.6.5    Inferior Vena Cava Filters (IVCF) .......................................................................... 153
                                         7.6.6    Peripheral Embolic Protection Devices.................................................................. 153
                                         7.6.7    Peripheral Guidewires ........................................................................................... 154
                                         7.6.8    PTA Peripheral Drug Eluting Balloons (DEB) ........................................................ 154
                                      7.7    Cardiovascular Monitoring and Diagnostic Devices ...................................................... 155
                                      7.8    Cardiovascular Monitoring and Diagnostic Devices - List of Pipeline Products............. 156
                                      7.9    Profiles of Key Pipeline Products - Cardiovascular Monitoring and Diagnostic Devices159
                                         7.9.1    ECG Monitoring Equipment ................................................................................... 159
                                         7.9.2    Holter Monitoring Systems .................................................................................... 160
                                         7.9.3    Cardiopulmonary Stress Testing Systems ............................................................. 160
                                         7.9.4    Event Monitoring Systems ..................................................................................... 161
                                      7.10 Cardiac Assist Devices ................................................................................................. 162
                                      7.11 Cardiac Assist Devices - List of Pipeline Products ........................................................ 163
                                      7.12 Profiles of Key Pipeline Products - Cardiac Assist Devices .......................................... 166
                                         7.12.1 Artificial heart ......................................................................................................... 166
                                         7.12.2 Ventricular Assist Device ....................................................................................... 166
                                      7.13 Electrophysiology .......................................................................................................... 168
                                      7.14 Electrophysiology - List of Pipeline Products ................................................................ 169
                                      7.15 Profiles of Key Pipeline Products - Electrophysiology ................................................... 172
                                         7.15.1 Electrophysiology Diagnostic Catheters ................................................................ 172
                                         7.15.2 Electrophysiology Aablation Catheters .................................................................. 172
                                         7.15.3 Electrophysiology Lab Systems ............................................................................. 173
                                      7.16 Prosthetic Heart Valves ................................................................................................ 174
                                      7.17 Prosthetic Heart Valves - List of Pipeline Products ....................................................... 175
                                      7.18 Profiles of Key Pipeline Products - Prosthetic Heart Valves.......................................... 178
                                         7.18.1 Tissue Heart Valves .............................................................................................. 178
                                         7.18.2 Closed-Chest Aortic Tissue Valve ......................................................................... 178
                                         7.18.3 Mechanical Heart Valves ....................................................................................... 178
                                         7.18.4 Transcatheter Heart Valves ................................................................................... 179
                                      7.19 Cardiovascular Surgery Devices ................................................................................... 181
                                      7.20 Cardiovascular Surgery Devices - List of Pipeline Products ......................................... 182
                                      7.21 Profiles of Key Pipeline Products - Cardiac Surgery Devices ....................................... 184
                                         7.21.1 Perfusion disposables ........................................................................................... 184
                                         7.21.2 Beating Heart Surgery System .............................................................................. 184
                                         7.21.3 Cardiopulmonary Bypass Equipment .................................................................... 185
                                         7.21.4 Cardiac Ablation Devices ...................................................................................... 186
                                      7.22 Cardiac Rhythm Management ...................................................................................... 187
                                      7.23 Cardiac Rhythm Management - List of Pipeline Products ............................................. 188
                                      7.24 Profiles of Key Pipeline products - Cardiac Rhythm Devices ........................................ 189
                                         7.24.1 Pacemakers........................................................................................................... 189
                                         7.24.2 Cardiac Resynchronisation Therapy...................................................................... 190

Cardiovascular Devices Market to 2017 - Minimally Invasive                                                           GBIME0048MR / Published FEB 2012
Techniques and Cardiac Prosthetic Devices to Drive Future                                                                                           Page 8
Growth                                                                           © GBI Research. This report is a licensed product and is not to be copied,
                                                                                                                 reproduced, shared or resold in any form
                                        7.24.3 Implantable Cardioverter Defibrillators .................................................................. 190
                                     7.25 Cardiovascular Prosthetic Devices ............................................................................... 192
                                     7.26 Cardiovascular Prosthetic Devices - List of Pipeline Products ...................................... 193
                                     7.27 Profiles of Key Pipeline Products - Cardiovascular Prosthetic Devices ........................ 195
                                        7.27.1 Cardiac Valve Repair............................................................................................. 195
                                        7.27.2 Septal Occluders ................................................................................................... 195
                                     7.28 External Defibrillators .................................................................................................... 196
                                     7.29 External Defibrillators: List of Pipeline Products............................................................ 196
                                     7.30 Profiles of Key Pipeline Products - External Defibrillators ............................................. 197
                                        7.30.1 External Defibrillators ............................................................................................ 197
                                   8 Global Cardiovascular Devices Market - Consolidation Landscape ........................................ 198
                                     8.1    Number of Deals, 2007-2011 ........................................................................................ 198
                                     8.2    Key Deals in 2007-2011(Q1-Q3)................................................................................... 203
                                        8.2.1    Boston Scientific acquires Atritech ........................................................................ 203
                                        8.2.2    Medtronic Completes Acquisition of Remaining Stake in Ardian ........................... 203
                                        8.2.3    St. Jude Medical Acquires AGA Medical holding ................................................... 204
                                        8.2.4    Covidien Acquires ev3 ........................................................................................... 204
                                        8.2.5    Medtronic Acquires ATS Medical........................................................................... 204
                                        8.2.6    Medtronic Acquires Invatec ................................................................................... 205
                                        8.2.7    Abbott Laboratories Acquires Evalve..................................................................... 205
                                        8.2.8    Covidien Acquires VNUS Medical Technologies Inc. ............................................ 206
                                        8.2.9    Medtronic Acquires CoreValve from Sofinnova Partners, Apax Partners, HealthCap
                                                 and Maverick Capital ............................................................................................. 206
                                        8.2.10 Medtronic Acquires Ventor Technologies .............................................................. 206
                                        8.2.11 Medtronic Acquires Ablation Frontiers ................................................................... 207
                                        8.2.12 MEDRAD Acquires Possis Medical ....................................................................... 207
                                        8.2.13 Teleflex Acquires Arrow International .................................................................... 207
                                   9 Appendix .....................................................................................................................
				
DOCUMENT INFO
Shared By:
Tags:
Stats:
views:172
posted:2/22/2012
language:English
pages:213
Description: “Cardiovascular Devices Market to 2017 - Minimally Invasive Techniques and Cardiac Prosthetic Devices to Drive Future Growth” provides key data, information and analysis on the global cardiovascular devices market. The report provides the market landscape, competitive landscape and market trend information on ten cardiovascular devices market categories: cardiac rhythm management, interventional cardiology, peripheral vascular devices, cardiovascular surgery, prosthetic heart valves, external defibrillators, electrophysiology, cardiovascular monitoring and diagnostic devices, cardiovascular prosthetic devices and cardiac assist devices. The report provides comprehensive information on the key trends affecting these categories, and key analytical content on the market dynamics. The report also reviews the competitive landscape and provides a detailed analysis of the pipeline products in each category. The report also reviews details about important merger and acquisition deals that have taken place in the cardiovascular devices market during the past four years. The report is compiled using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.
BUY THIS DOCUMENT NOW PRICE: $3500 100% MONEY BACK GUARANTEED
PARTNER GBI Research
GBI Research is a market-leading provider of business intelligence reports. GBI Research covers worldwide markets and issues, supplies actionable data and forecasts and is driven by industry leaders’ insights. GBI Research provides a broad spectrum of reports across the healthcare and energy industries and its online offering is easy to navigate - a comprehensive resource for business information needs. Headquartered in the UK, the company has branches in the US and Asia, and provides world class client support and service.